Qisheng Luo1,2, Hongcheng Luo3, Huangde Fu2, Haineng Huang2, Huadong Huang2, Kunxiang Luo2, Chuanyu Li2, Rentong Hu3, Chuanhua Zheng2, Chuanliu Lan2, Qianli Tang1,4. 1. College of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China. 2. Department of Neurosurgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, China. 3. Department of Laboratory Medicine, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, China. 4. Department of Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, China.
Abstract
OBJECTIVE: To investigate the effect of curcumin on the invasion and migration of human glioma cells in vitro and explore the molecular mechanisms. METHODS: MTT assay was used for screening the optimal curcumin concentrations. The effects of curcumin on the invasion and metastasis of human glioma cell lines U251 and LN229 were tested using Transwell assay, Boyden assay and wound-healing assays. The expression of the related proteins and their interactions were determined using Western blotting and coimmunoprecipitation assay. RESULTS: Curcumin at the concentration of 20 μmol/L for 48 h was used as the optimal condition for subsequent cell treatment. In the two glioma cell lines, curcumin significantly suppressed the invasion and migration of the cells (P < 0.05) and lowered the expressions of hepatoma-derived growth factor (HDGF), Ncadherin, vimentin, Snail and Slug, but increased the expression of E-cadherin. Interference of HDGF in curcumin-treated glioma cells synergistically inhibited the epithelial-mesenchymal transition (EMT) signals, while overexpression of HDGF significantly reversed the inhibitory effect of curcumin on EMT; curcumin treatment could significantly reduce the binding of HDGF to β-catenin. CONCLUSIONS: Curcumin suppresses EMT signal by reducing HDGF/β-catenin complex and thereby lowers the migration and invasion abilities of human glioma cells in vitro.
OBJECTIVE: To investigate the effect of curcumin on the invasion and migration of humanglioma cells in vitro and explore the molecular mechanisms. METHODS:MTT assay was used for screening the optimal curcumin concentrations. The effects of curcumin on the invasion and metastasis of humanglioma cell lines U251 and LN229 were tested using Transwell assay, Boyden assay and wound-healing assays. The expression of the related proteins and their interactions were determined using Western blotting and coimmunoprecipitation assay. RESULTS:Curcumin at the concentration of 20 μmol/L for 48 h was used as the optimal condition for subsequent cell treatment. In the two glioma cell lines, curcumin significantly suppressed the invasion and migration of the cells (P < 0.05) and lowered the expressions of hepatoma-derived growth factor (HDGF), Ncadherin, vimentin, Snail and Slug, but increased the expression of E-cadherin. Interference of HDGF in curcumin-treated glioma cells synergistically inhibited the epithelial-mesenchymal transition (EMT) signals, while overexpression of HDGF significantly reversed the inhibitory effect of curcumin on EMT; curcumin treatment could significantly reduce the binding of HDGF to β-catenin. CONCLUSIONS:Curcumin suppresses EMT signal by reducing HDGF/β-catenin complex and thereby lowers the migration and invasion abilities of humanglioma cells in vitro.
Authors: Jakob Weissenberger; Maike Priester; Christian Bernreuther; Stefanie Rakel; Markus Glatzel; Volker Seifert; Donat Kögel Journal: Clin Cancer Res Date: 2010-12-01 Impact factor: 12.531
Authors: Muthu K Shanmugam; Grishma Rane; Madhu Mathi Kanchi; Frank Arfuso; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Benny K H Tan; Alan Prem Kumar; Gautam Sethi Journal: Molecules Date: 2015-02-05 Impact factor: 4.411
Authors: Ping Chen; Han-Peng Huang; Yi Wang; Jun Jin; Wei-Guo Long; Kan Chen; Xiao-Hui Zhao; Chen-Guo Chen; Jian Li Journal: J Exp Clin Cancer Res Date: 2019-06-13
Authors: Ozal Beylerli; Aferin Beilerli; Alina Shumadalova; Xiaoxiong Wang; Mingchun Yang; Hanran Sun; Lei Teng Journal: Front Cell Dev Biol Date: 2022-10-04